October 22, 2007
3. Outline of Parties to the Share Exchange
| (1) | Trade Name | Kyowa Hakko Kogyo, Co., Ltd. | Kirin Pharma Company, Limited |
| (2) | Business Description | Production and sales of pharmaceutical products for medical professionals, raw materials for pharmaceutical/industrial use, healthcare products, products for the agriculture and livestock industry and the fishing industry, etc. | Production and sales of pharmaceutical products |
| (3) | Date of Incorporation | July 1, 1949 | April 25, 1958 (Commencement of operation on July 1, 2007) |
| (4) | Address of Head Office | 1-6-1 Ohtemachi, Chiyoda-ku, Tokyo | 6-26-1 Jingumae, Shibuya-ku, Tokyo |
| (5) | Name and Title of Representative | Yuzuru Matsuda President and CEO |
Katsuhiko Asano President and Chairman of the Board of Directors |
| (6) | Paid-in Capital | 26,745 million yen (as of March 31, 2007) |
3,000 million yen (as of July 1, 2007) |
| (7) | Number of Issued Shares | 399,243,555 shares (as of March 31, 2007) |
30,000 shares (as of July 1, 2007) |
| (8) | Total Asset | 378.8 billion yen (consolidated) (as of March 31, 2007) |
76.6 billion yen (nonconsolidated) (as of July 1, 2007) |
| (9) | Net Asset | 244.0 billion yen (consolidated) (as of March 31, 2007) |
63.0 billion yen (nonconsolidated) (as of July 1, 2007) |
| (10) | Fiscal Year End | March 31 | December 31 |
| (11) | Number of Employees | 5,756 (consolidated) (as of March 31, 2007) |
1,270 (nonconsolidated) (as of July 1, 2007) |
| (12) | Major business partners | Mediceo Paltac Holdings Co., Ltd. Suzuken Co., Ltd. Alfresa Corporation |
Alfresa Corporation Toho Pharmaceutical Co., Ltd. Suzuken Co., Ltd. |
| (13) | Major Shareholders and Shareholding Ratio | The Master Trust Bank of Japan Ltd. (Trust Account): 6.33% The Dai-ichi Mutual Life Insurance Company: 6.17% Japan Trustee Services Bank, Ltd. (Trust Account): 5.60% The Norinchukin Bank: 4.52% Mizuho Trust & Banking Co., Ltd. Retirement Benefit Trust Account for Mizuho Bank, Ltd. Asset Management Re-entrust Services: 2.02% (as of March 31, 2007) |
Kirin Holdings: 100% (Excluding treasury stock) (as of July 1, 2007) |
| (14) | Major Banks | Mizuho Corporate Bank, Ltd. The Norinchukin Bank |
The Bank of Tokyo-Mitsubishi UFJ, Ltd. |
| (15) | Relationship with the New Company | Capital relationship | None |
| Personal relationship | None | ||
| Transaction relationship | None | ||
| Status of relationship with related parties | None |
| (16) Business results for the Three Most Recent Fiscal Periods (Consolidated) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (hundred millions of yen) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| * | For Kirin Pharma, the above figures are the business results of the business segment. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| * | Because Kirin Pharma is an unlisted company, items other than the net sales and operating income in the table above are not disclosed. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
